Global In-Vitro Diagnostics (IVD) Market to Grow on the Back of Growing Prevalence of Chronic Diseases; Market to Grow with a CAGR of 4.6% During 2022-2031
Kenneth Research has released a report titl... View MoreGlobal In-Vitro Diagnostics (IVD) Market to Grow on the Back of Growing Prevalence of Chronic Diseases; Market to Grow with a CAGR of 4.6% During 2022-2031
Kenneth Research has released a report titled “In-Vitro Diagnostics (IVD) Market: Global Demand Analysis & Opportunity Outlook 2031” which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, along with the impact of COVID-19 and a detailed discussion on the latest trends and future opportunities that are associated with the growth of the market.
Each year, over 15 Million people between the ages of 30 and 69 years, according to the statistics by the World Health Organization (WHO), are known to die from a noncommunicable disease (NCD).
Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.kennethresearch.com/sample-request-10352392
The statistics portray the rising prevalence of chronic diseases across the globe which in turn, is driving the need amongst the healthcare service providers to develop advanced diagnostic devices that can pre-diagnose these chronic diseases. Moreover, with the surge in prevalence of different types of infectious diseases around the world, such as HIV, AIDS, tuberculosis, and pneumonia among others, the healthcare organizations are increasing working on the research and development of IVDs, which is also projected to boost the market growth.
The global in-vitro diagnostics (IVD) market is anticipated to grow with a CAGR of 4.6% over the forecast period, i.e., 2022 – 2031. The market is estimated to garner a revenue of USD 135167.7 Million by the end of 2031, Additionally, in the year 2021, the market generated a revenue of USD 87236.4 Million. The market is segmented by product into reagents, instruments, and services. The reagents segment, out of all the other segments, is projected to garner the largest revenue of USD 112156.4 Million by the end of 2031. Moreover, the segment garnered a revenue of USD 71786.2 Million in the year 2021.
By region, the global in-vitro diagnostics (IVD) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region, out of which, the market in North America is projected to garner the largest revenue of USD 57175.9 Million by the end of 2031. Moreover, the market generated a revenue of USD 36988.2 Million in the year 2021.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Browse Full Report @ https://www.kennethresearch.com/report-details/in-vitro-diagnostics-ivd-market/10352392
However, the operational barriers faced during conduction of diagnostic tests, along with dynamic regulatory landscape are predicted to hinder the market growth.
This report also provides the existing competitive scenario of some of the key players of the global in-vitro diagnostics (IVD) market, which includes company profiling of Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Sysmex Corporation, Qiagen GmbH, bioMerieux SA, Danaher Corporation, Bio Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Exact Sciences Corporation, Becton, Dickinson and Company, and others.
The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments.
Conclusively, the report titled “In-Vitro Diagnostics (IVD) Market: Global Demand Analysis & Opportunity Outlook 2031”, analyses the overall global in-vitro diagnostics (IVD) industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the global in-vitro diagnostics (IVD) market in the near future.
Request Sample Report@ https://www.kennethresearch.com/sample-request-10352392
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact for more Info
:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 313 462 0609
The global in-vitro diagnostics (IVD) market is anticipated to grow with a CAGR of 4.6% over the forecast period, i.e., 2022 – 2031.
page=1&profile_user_id=8158&year=&month=
Load More
